BioNTech Tumbles as Founding Duo Plan to Leave to Start New Firm

BioNTech SE’s founders will leave the company to start a new biotech focused on messenger RNA, the technology behind their ...
The Edge Singapore

BioNTech founders leaving to start new firm; shares slide

BioNTech SE’s founders will leave the company to start a new biotech focused on messenger RNA, the technology behind their blockbuster Covid-19 vaccine.
Euractiv

BioNTech founders quit CEO roles to build AI-powered mRNA therapies

Right before BioNTech was due to announce its 2025 results, the company’s co‑founders, Ugur Sahin and Özlem Türeci, revealed they would leave the company to focus on develop ...
Devdiscourse

BioNTech Founders Forge New Path: A Return to Early Discovery

BioNTech's co-founders, Ugur Sahin and Oezlem Tuereci, plan to leave by year's end to start a new venture, causing BioNTech's shares to plummet. The couple aims to focus on mRNA-based drugs at an ...
Devdiscourse

BioNTech Founders to Launch New Venture, Shifting Focus to mRNA-Driven Drug Discovery

BioNTech's co-founders, Ugur Sahin and Oezlem Tuereci, will leave the company by 2026 to establish a new venture focused on next-generation mRNA drugs. Although BioNTech's stock plummeted following ...